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Abstract
Background: To evaluate the knowledge, attitudes and beliefs about adult male circumcision (AMC), assess the
association of AMC with HIV incidence and prevalence, and estimate AMC uptake in a Southern African
community.
Methods: A cross-sectional biomedical survey (ANRS-12126) conducted in 2007-2008 among a random sample of
1198 men aged 15 to 49 from Orange Farm (South Africa). Face-to-face interviews were conducted by structured
questionnaire. Recent HIV infections were evaluated using the BED incidence assay. Circumcision status was self-
reported and clinically assessed. Adjusted HIV incidence rate ratios (aIRR) and prevalence ratios (aPR) were
calculated using Poisson regression.
Results: The response rate was 73.9%. Most respondents agreed that circumcised men could become HIV infected
and needed to use condoms, although 19.3% (95%CI: 17.1% to 21.6%) asserted that AMC protected fully against
HIV. Among self-reported circumcised men, 44.9% (95%CI: 39.6% to 50.3%) had intact foreskins. Men without
foreskins had lower HIV incidence and prevalence than men with foreskins (aIRR = 0.35; 95%CI: 0.14 to 0.88; aPR =
0.45, 95%CI: 0.26 to 0.79). No significant difference was found between self-reported circumcised men with
foreskins and other uncircumcised men. Intention to undergo AMC was associated with ethnic group and partner
and family support of AMC. Uptake of AMC was 58.8% (95%CI: 55.4% to 62.0%).
Conclusions: AMC uptake in this community is high but communication and counseling should emphasize what
clinical AMC is and its effect on HIV acquisition. These findings suggest that AMC roll-out is promising but requires
careful implementation strategies to be successful against the African HIV epidemic.
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Background
The protective effect of adult male circumcision (AMC)
on HIV acquisition has been reported in a review of epi-
demiological studies [1] and demonstrated by three ran-
domized controlled trials conducted in Southern and
Eastern Africa, which found that the risk of HIV acqui-
sition among circumcised adult men was reduced by
about 60% [2-4]. As a health intervention, AMC is pre-
dicted to be significantly life- and cost-saving in terms
of averted HIV infections and related medical costs
[5-8].
In 2007, WHO/UNAIDS recommended AMC as an
important, additional intervention which should be
delivered as part of a comprehensive HIV prevention
package in communities with generalized HIV epidemics
and low AMC prevalence [9]. Since this recommenda-
tion, efforts are being applied to roll-out safe and effec-
tive AMC services in several Eastern and Southern
African countries [10-12].
A review of studies investigating the acceptability of
AMC as an intervention against HIV among Sub-
Saharan African communities not practicing male
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ability among men was defined as their willingness to
undergo the procedure. This review reported medium-
high to high acceptability of AMC, if performed safely
and at minimal cost, of 65% (95% confidence interval
(CI): 29% to 87%) among men for themselves. As this
review of acceptability studies was conducted before all
AMC trials results were known, higher levels of accept-
ability may be expected following the WHO/UNAIDS
recommendation [9].
Little is known however about the extent to which
AMC as an intervention against HIV would be actually
taken up in these communities. As demonstrated by
modeling studies [6,14,15], the uptake of AMC is a key
condition for a successful roll-out because it will condi-
tion the impact of the intervention on the spread of HIV.
The most frequently reported barriers to AMC uptake in
African communities, which are cost and surgical safety
[13], are addressed when providing free medicalised
AMC. Nonetheless, other factors may facilitate or inhibit
intention to undergo AMC, and their identification is
necessary to refine outreach and communication strate-
gies, design effective AMC delivery models, and optimize
the impact of AMC interventions on the HIV epidemic.
The overall aim of this study was to conduct an
operational study of AMC uptake in a South African
community. Specifically, the objectives were to a) evalu-
ate community knowledge, attitudes and beliefs about
male circumcision, b) assess male circumcision’s associa-
tion with HIV incidence and prevalence in the commu-
nity, c) identify the demographic, biomedical, social,
behavioral, and knowledge factors associated with inten-
tion to undergo AMC and d) estimate the uptake of free
medicalised AMC as an intervention against HIV.
Methods
Study context
The study (ANRS-12126) was conducted from October
2007 to April 2008 in the township of Orange Farm,
located south of Johannesburg in the Gauteng province of
South Africa. The first published randomized clinical trial
on the effect of AMC on HIV acquisition was conducted
in this community in 2002-2005 [2]. The township has an
estimated population of 200,000 living in an area of about
50 km
2. A study conducted in a neighboring, comparable
township, estimated self-reported circumcision prevalence
at 22.4%, and clinical circumcision prevalence (lack of
foreskin) at 13%, with male circumcision being perceived
positively [16]. HIV prevalence in the province is esti-
mated at 15.2% among adults aged 15 to 49 [17].
Study recruitment
Screening for the biomedical survey was conducted
according to a method designed for a community-based
cross-sectional study conducted in the same area [16].
Briefly, a random sample of 1680 households was
selected from Statistics South Africa Enumerator Area
aerial photographs. The survey was self-weighted by
dividing the township into clusters of similar housing
types. In each cluster, the number of households ran-
domly selected depended on the total number of house-
holds and the average number of inhabitants per
household. All men aged 15 to 49, who had slept in
these households the night before the visit of the inves-
tigative team, were eligible for inclusion. Voluntary,
written informed consent was required, in addition to
parental consent for those aged under 18.
Data collection
Each participant was interviewed face-to-face at the
study site in his or her preferred language using an
anonymous structured standardized questionnaire
adapted from an instrument designed by UNAIDS [18].
The following data were collected: Background charac-
teristics, including self-reported circumcision status; sex-
ual behavior and condom use; attitudes towards HIV;
knowledge, attitudes and beliefs towards AMC; intention
to undergo free medicalised male circumcision from all
self-reported uncircumcised participants.
Counseling and HIV testing
Each interview was followed by an individual counseling
session, which included general information about HIV
and STI prevention, with a specific focus on the effect
of AMC on HIV, emphasizing the partial protection of
AMC against HIV acquisition and the need for consis-
tent condom use. Participants were encouraged to
undergo HIV testing, which was provided at the study
site using rapid tests. Self-reported uncircumcised men
were offered free medicalised AMC. Those who
accepted the procedure received an AMC voucher with
their name and photo.
Genital examination
Male participants underwent a health examination per-
formed by a trained male nurse during which their clini-
cal circumcision status (presence or absence of foreskin)
was assessed.
Laboratory procedures
Each participant was asked to supply a venous blood
sample (8 ml) for HIV and Herpes Simplex Virus 2
(HSV-2) testing. Samples were collected in plasma pre-
paration tubes, centrifuged and harvested in aliquots (2
× 1.8 ml). A screening test (Genscreen HIV1/2 version
2, Bio-Rad, France) was performed on all aliquots. For
reactive samples, a confirmatory test was run (Vironos-
tika HIV Uni-Form II plus O, bioMérieux, Netherlands).
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confirmatory test was conducted (Murex HIV-1.2.O,
Murex Biotech Ltd., UK). Plasma samples testing posi-
tive for HIV were retested using a HIV incidence assay
(Calypte HIV-1 BED Incidence EIA (BED), Calypte Bio-
medical Corporation, USA), according to the manufac-
turer’s protocol. HSV-2 testing was performed using the
Kalon HSV-2 gG2 assay (Kalon Biological Ltd., UK).
Management of STI and HIV-positive persons
Participants with symptomatic STIs were treated free of
charge at the study site or at local health facilities. Indi-
viduals testing HIV positive were offered an immediate
CD4 count at the study site. For CD4 counts of less
than 200/ml, antiretroviral treatment (ART) was
arranged in collaboration with the health facilities deli-
vering ART in the community.
AMC surgery
To undergo AMC surgery, willing men had to agree to
follow the instructions provided by the medical team,
especially abstaining from sexual activity for 6-weeks
after being circumcised. Volunteers with contraindica-
tions for AMC surgery, such as allergy to anesthesia,
hemophilia, bleeding disorders, genital ulceration, symp-
tomatic STIs, signs of infections, abnormal genital anat-
omy or history of diabetes, were excluded. AMC
surgeries were performed by trained medical doctors
according to WHO surgical recommendations [19] using
the forceps guided method, electrocautery, and sterilized
disposable circumcision kits. The AMCs were standar-
dized and performed using task-sharing by a medical
team composed of five nurses and a medical circumciser,
as described elsewhere [20]. After the procedure, partici-
pants were provided with analgesics for the relief of pain,
given detailed postoperative instructions on wound care
and management, including the mandatory 6-week absti-
nence from sexual activities, and asked to return to the
centre for one follow-up visit, 2 to 4 days after surgery.
Additional sample
To increase the power of the analyses testing the asso-
ciations of reported and clinical male circumcision sta-
tus with HIV incidence and prevalence, an additional
random sample of 802 men aged 16 to 29 was surveyed
one month after the end of the initial survey. These
men were selected as described above and underwent
the same procedures but a simplified questionnaire was
used.
Statistical Methods
Participants were compared by self-reported circumci-
sion status and clinical circumcision status. For continu-
ous data, medians and interquartile ranges (IQR) were
computed, and significance testing was carried out using
the Kruskal-Wallis test. Median and IQR of age at first
sexual intercourse were computed using Kaplan-Meier
survival analysis and compared between groups using
the log-rank test. For categorical data, proportions were
computed and compared between groups using Pear-
son’s Chi square or Fisher exact tests, as applicable, and
95% confidence intervals (CI) were obtained by Bayesian
calculations.
The comparison between self-reported circumcised
men and self-reported uncircumcised men was per-
formed among men aged 22 and older. In this age
group, the median age at circumcision was 19 (IQR =
16-21), hence most of those who wanted to become cir-
cumcised were already circumcised. This prevented a
dilution effect that could have occurred if younger men
had been included since they could still become circum-
cised in the future.
Unadjusted odds ratios (OR) and adjusted OR (aOR)
were computed using univariate and multivariate logistic
regression analyses to assess the association of covariates
with the following dichotomous variables: a) self-report-
ing as uncircumcised among all men aged 22 and older
b) having an intact foreskin among all self-reported cir-
cumcised men and c) intending to undergo free and
medicalised AMC among self-reported uncircumcised
men. For the multivariate analyses, a forward stepwise
procedure, with age and ethnic group being forced into
the model, was used to select the significant covariates.
H I Vi n c i d e n c er a t e sw e r ec alculated using the BED
assay results with a cut-off value of 1.89, which corre-
sponds to an assay window period of about 15 months,
and with correction for misclassifications according to a
published method [21]. Using Poisson regression,
adjusted HIV incidence rate ratios (aIRR) and adjusted
HIV prevalence ratios (aPR) were calculated, between a)
self-reported circumcised men with foreskins and self-
reported uncircumcised men with foreskins, and b) men
clinically uncircumcised (with foreskins) and men clini-
cally circumcised (without foreskin). We have also cal-
culated the aIRR when using a cutoff of 1.51,
corresponding to an assay window period of about 12
months. All analyses were adjusted on the relevant
demographic and sexual behavior covariates listed in the
data collection section above. To optimize these ana-
lyses, aIRR and aPR calculations were conducted among
men aged 22 to 34, the age range in which HIV preva-
lence increases with age, and time since circumcision is
at least two years. The estimated IRR were corrected for
BED assay misclassifications. The details of the correc-
tions are provided in the Additional file 1.
AMC uptake was calculated as the proportion of men
who used the AMC vouchers to undergo AMC among
all uncircumcised men aged 15 to 49.
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tical package SPSS version 8.0 for Windows (SPSS Inc.,
Chicago, IL, USA) and R version 2.10.1 [22].
Ethics
Ethical clearance was granted by the Human Research
Ethics Committee (Medical)o ft h eU n i v e r s i t yo ft h e
Witwatersrand on May 8th, 2007 (protocol study no.
M070367).
Results
Characteristics of survey participants by self-reported
circumcision status
The household and individual combined response rate
was 73.9%. Among the 1198 male respondents, 334
(27.9%; 95%CI: 25.4% to 30.5%) self-reported as circum-
cised. Background characteristics, sexual behavior, atti-
tudes towards HIV, and prevalence of HIV and HSV-2
are reported by self-reported circumcision status in
Table 1. Multivariate analysis indicated that self-
reported uncircumcised men were more likely to be
aged 27 or older (aOR = 1.72; 95%CI: 1.15 to 2.56),
more often from Zulu (traditionally non-circumcising)
than Sotho (traditionally circumcising) ethnicity (aOR =
1.84; 95%CI: 1.22 to 2.77), more often single than ever
married (aOR = 2.06; 95%CI: 1.20 to 3.55), more likely
to have initiated sexual activity after the age of 16 (aOR
= 1.55; 95%CI: 1.09 to 2.21), more often HIV-positive
(aOR = 1.91; 95%CI: 1.20 to 3.03) and less likely to be
aware of their HIV status (aOR = 0.65; 95%CI: 0.46 to
0.93). No association was found with key factors asso-
ciated with increased risk of HIV acquisition, such as
number of sexual partners and lack of consistent con-
dom use with non-spousal partners.
Clinical circumcision status and HIV risk
Following genital examination, it was observed that
44.9% (95%CI: 39.6% to 50.3%) of self-reported circum-
cised men had intact foreskins, whereas 99.7% (95%CI:
99.1% to 99.9%) of self-reported uncircumcised men had
foreskins. Self-reported circumcised men represented
14.8% (95%CI: 12.7% to 17.1%) of all men with foreskins.
In multivariate analysis, among self-reported circum-
cised men, having an intact foreskin was associated with
older age (Plinear trend = 0.01), being of Zulu or Sotho
ethnicity (aOR = 3.4; 95%CI: 1.90 to 6.09), having
attended initiation school (aOR 7.7; 95%CI: 4.48 to
13.30) and being a scholar or a student (aOR = 3.58;
95%CI: 1.74 to 7.37).
Clinically circumcised men had a mean time since cir-
cumcision of 8.8 years (median = 6.5 years; IQR: 4.5
years-11.5 years). Among these men, six were tested
recent seroconverters and 193 were HIV-negative, corre-
sponding to an HIV incidence of 0.022 per person-year.
Among clinically uncircumcised men, the corresponding
figures were 37, 462 and 0.056 per person-year. The IRR
was 0.40 (95%CI: 0.16 to 0.98; P = 0.05). Among clini-
cally circumcised men, HIV aIRR was about two-thirds
lower and HIV aPR was more than half lower than
among all other men (Figures 1 and 2). When using an
assay window period of about 12 months, the aIRR was
0.30 (95%CI: 0.10 to 0.80), which is close to the value
found with the 15 months assay window.
No differences in HIV incidence and prevalence
between self-reported circumcised men with a foreskin
and other uncircumcised men were detected. There was
no significant variation of the protective effect of AMC
with time since circumcision. On average, this effect
increased the aIRR by 4.1% per year (95%CI: -4.1% to
11.6%, P linear trend = 0.27), corresponding to a non sig-
nificant weaker effect.
Knowledge, attitudes and beliefs towards AMC
Knowledge, attitudes and beliefs towards AMC, by
reported circumcision status, are detailed in Table 2.
Most respondents agreed that circumcised men could
become HIV infected (92.6%; 95% CI: 91.0% to 94.0%)
and needed to use condoms (90.0%; 95% CI: 88.2% to
91.6%), although 19.3% (95% CI: 17.1% to 21.6%)
asserted that AMC protected fully against HIV. When
compared with self-reported uncircumcised men, self-
reported circumcised men were more likely to believe
that women preferred circumcised men, that AMC
increased sexual pleasure, that circumcised men did not
need to use condoms and to report that their partners
and families supported AMC.
Intention to undergo AMC and AMC uptake
Among the 861 self-reported and clinically uncircum-
cised men, 699 (81.2%; 95%CI: 78.4% to 83.7%) stated
that they would want to undergo AMC if it was free
and performed by a doctor.
Among these men, the most frequently stated reasons
for not being circumcised were pain (21.5%; 95%CI:
18.5% to 24.6%), AMC not being part of one’sc u l t u r e
(12.6%; 95%CI: 10.3% to 15.2%), and the risks (10.0%;
95%CI: 7.9% to 12.4%) and costs (6.2%; 95%CI: 4.5% to
8.1%) associated with the procedure. A sizeable propor-
tion of the respondents (22.5%; 95%CI: 19.5% to 25.6%)
reported no specific reason.
In the multivariate analysis, intention to undergo
AMC was associated with ethnic group, believing that
medicalised AMC was safe and partner and family sup-
port of AMC (Table 3).
Among men reporting intention to undergo AMC,
72.4% (506/699) were circumcised through the study.
Uptake of AMC was 58.8% (506/861; 95%CI: 55.4% to
62.0%).
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Men aged 22 and over
Self-reported circumcised Self-reported uncircumcised P-value
2
Sample size 234 374
Background Characteristics
Age
Mean (median) 29.1 (26) 29.9 (28) 0.07
IQR 24-33 24-34
Ethnic group (%)
Sotho 32.9 27.8
Zulu 34.6 50.8 <0.001
Other 32.5 21.4
Religion (%)
Christian 36.3 35.3 0.09
No religion 44.0 51.1
Other 19.7 13.6
Education (%)
Grade 12 completed 28.6 27.0 0.71
Occupation (%)
Employed 57.7 58.6
Unemployed 28.6 31.0
Scholar or student 4.3 4.0 0.57
Other 9.4 6.4
Marital status (%)
Ever married 36.5 31.8 0.31
Committed to someone 46.8 47.1
Single 16.7 21.1
Initiation school attendance (%)
42.5 3.5 <0.001
Reported sexual behavior
Ever had sexual intercourse (%)
99.6 98.7 0.41
Age at first sexual intercourse (year)
Mean (median) 16.1 (16) 16.7 (16) 0.02
IQR 14.0-17.0 15.0-18.0
Number of lifetime sexual partners
1
Mean (median) 16.2 (10) 13.8 (8) 0.19
IQR 5-20 4-15
Number of sexual partners in the past 12 months
1
Mean (median) 2.8 (2) 2.5 (2) 0.04
IQR 1.0-3.0 1.0-3.0
Ever used a condom
1 (%)
90.1 86.2 0.16
Consistent condom use in the past 12 months, with non-spousal partners (%)
26.6 34.5 0.08
Attitudes towards HIV
Perceived risk of HIV infection (%)
No or small risk 48.7 43.2 0.36
Average or high risk 32.5 37.5
No opinion 18.8 19.3
Aware of HIV status (%)
42.3 32.9 0.02
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This operational study of AMC uptake in a South Afri-
can community indicates that when offered free medica-
l i s e dA M C ,m o r et h a nh a l fo fs e l f - r e p o r t e d
uncircumcised men choose to become circumcised.
Furthermore, the study reveals that about half of self-
reported circumcised men in the study had foreskins,
and that when considering only men with foreskins,
HIV prevalence did not differ between self-reported cir-
cumcised men and self-reported uncircumcised men.
Conversely, the reported protective effect of clinical cir-
cumcision on HIV acquisition was higher than what was
reported in the three male circumcision trials [2-4]. The
study also established that most men in the community
had a fairly good knowledge of AMC and its association
with HIV acquisition, despite some misconceptions, and
s u g g e s t e dt h a ti n t e n t i o nt ou n d e r g oA M Cw a sa s s o -
ciated with social factors. No association was found
between self-reported circumcision status and risky
sexual behavior. Furthermore, men willing to become
circumcised were neither more nor less likely to be
HIV-positive or at higher or lower risk of acquiring HIV
than men who were not willing to undergo the proce-
dure. Lastly, no evidence of a variation of the protective
effect of AMC on HIV incidence with time since cir-
cumcision was found.
It is not possible to compare the uptake reported here
with other findings since this is, to the best of our
knowledge, the first study on AMC uptake conducted
among a random sample representative of the general
population. However, another South African study has
reported an uptake of 33%, lower than the present esti-
mate, in a non-random AMC study nested in an HIV
efficacy trial [23].
This study has two main limitations. The first limitation
is that it was only possible to determine the characteristics
of participants who reported intention to undergo AMC,
and not of those who actually underwent surgery, due to
Table 1 Survey participants?’? characteristics, by self-reported circumcision status (Continued)
Sexually transmitted infections
HIV-positive
15.0 25.1 0.003
HSV-2 positive
30.8 35.6 0.25
HSV-2: Herpes Simplex Virus 2
1 Among those having had sexual intercourse
2 P-values were obtained when comparing self-reported uncircumcised men and self-reported circumcised men using Kruskal-Wallis, Pearson’s Chi square, Fisher’s
exact or log-rank test, as applicable
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than 70% of the men who reported intention to undergo
AMC were circumcised. A second limitation is that this
study was conducted in the township where the first AMC
trial was conducted, which may have influenced the deci-
sion to undergo AMC and could have enhanced commu-
nity knowledge about the association between AMC and
HIV acquisition. It is unlikely because a survey conducted
in 2008 among a random sample of male residents found
that only 2.1% knew the results of the AMC trial [20].
Nonetheless, even if Orange Farm is considered a typical
South African township, some caution should be used
when generalizing these results to other South African
communities or to other countries.
One of the most interesting findings of this study is
the fact that almost half of self-reported circumcised
men had in fact an intact foreskin. This is most prob-
ably due to the initiation rituals which are customarily
practiced in Southern and Eastern Africa. In South
Africa, and this may also be true elsewhere, the initia-
tion rituals may or may not involve the actual removal
of the foreskin [24,25]. Hence, men having undergone
such initiation rituals, usually around puberty, may call
themselves “circumcised”, even if their foreskin is
intact. This may also explain the apparent contradic-
tions in knowledge, attitudes & beliefs about AMC and
“circumcised” men found in this study.
The study findings, along with other examples of
AMC roll-out interventions which are ongoing in
Kenya, Botswana, Swaziland, Zambia and Zimbabwe
[12], provide evidence that a satisfactory uptake can be
expected from the AMC scale-up interventions that are
on-going in other countries of Southern and Eastern
Africa [10]. Furthermore, the findings indicate that such
interventions are likely to reach men from the general
population and not just those who are at higher or
lower risk of HIV infection. Therefore, if a high uptake
is obtained, the effect of AMC roll-out on HIV preva-
lence at population level may be substantial after some
years, as predicted by modeling studies [6,14,26].
The study has some important implications for the
planning of AMC roll-out. First, men who think that
they are circumcised but who are not in reality must be
reached. A possibility would be to include in the com-
munication and information documentation photos and
diagrams that illustrate what a circumcised penis looks
like. A randomized trial aiming to assess methods to
improve the self-reporting of male circumcision status
among men and their partners was conducted in 2010
in Swaziland and Zambia [12]. The upcoming results of
this trial will be helpful to identify the best approach.
Secondly, it is likely that AMC roll-out interventions
will require extensive communication campaigns to
explain what clinical AMC is and its effect on HIV
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Page 7 of 12acquisition. Indeed, in Orange Farm, despite a high
acceptability of male circumcision and the availability of
clinical AMC in the community at a cost of about 40
Euros in most local medical practices, only about 15%
of the men are clinically circumcised. In the present
study, to achieve the reported uptake, free medicalised
AMC was offered to each eligible man during individual
counseling sessions. It is unknown whether such
individual contacts will still be required once national
AMC campaigns are launched. Thirdly, the AMC pro-
motion campaigns should target both primary and sec-
ondary audiences. Indeed, the importance of family and
partners support of AMC on intention to undergo clini-
cal AMC is a noteworthy finding. Fourthly, the partial
protective effect of AMC should be central to communi-
cation and counselling strategies. Although current
Table 2 Knowledge, attitudes and beliefs towards adult male circumcision (AMC), by self-reported male circumcision
status
Men aged 22 and over
Self-reported circumcised Self-reported uncircumcised P-value
1
Sample size 234 374
AMC protects fully against HIV (%)
Agree 22.2 16.0 0.06
Disagree 61.5 61.5
Do not know 16.2 22.5
Most women prefer circumcised men (%)
Agree 70.9 56.1 0.001
Disagree 10.3 14.4
Do not know 18.8 29.4
AMC increases sexual pleasure (%)
Agree 68.4 36.1 < 0.001
Disagree 16.2 19.0
Do not know 15.4 44.9
Circumcised men do not need to use condoms for protection against HIV and other STIs (%)
Agree 6.4 4.8 0.01
Disagree 91.0 86.6
Do not know 2.6 8.6
Circumcised men can become infected with HIV (%)
Agree 93.2 90.9 0.13
Disagree 3.8 2.7
Do not know 3.0 6.4
My partner supports AMC (%)
Agree 68.4 42.8 < 0.001
Disagree 9.8 22.2
Do not know 21.8 35.0
My family supports AMC (%)
Agree 85.5 46.0 < 0.001
Disagree 10.3 37.7
Do not know 4.3 16.3
AMC is safe when carried by a doctor (%)
Agree 87.2 90.6 0.41
Disagree 4.7 3.5
Do not know 8.1 5.9
I would prefer to have my male children circumcised (%)
Yes 96.6 78.1 < 0.001
No 3.4 21.9
STIs: sexually transmitted infections
1 P-values were obtained using Pearson’s Chi square or Fisher exact tests, as applicable.
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reported uncircumcised men aged 22 and over
Intention to undergo AMC % (N) Univariate Odds ratio
1 (95%CI) Adjusted Odds ratio
2 (95%CI)
Background Characteristics
Age
Less than 27 85.8 (162) 1 1
27 and over 76.6 (209) 0.54 (0.31 to 0.93) P = 0.03 0.63 (0.32 to 1.14) P = 0.10
Ethnic group
Sotho 89.4 (104) 1 1
Zulu 77.2 (189) 0.40 (0.23 to 0.82) P = 0.01 0.36 (0.17 to 0.79) P = 0.01
Other 76.9 (78) 0.39 (0.17 to 0.89) P = 0.03 0.33 (0.13 to 0.80) P = 0.02
Religion
Christian 81.1 (132) 1 NS
No religion 78.2 (188) 0.83 (0.48 to 1.46) P = 0.53
Other 88.2 (51) 1.70 (0.66 to 4.61) P = 0.25
Education: grade 12 completed
No 80.8 (217) 1 NS
Yes 80.0 (100) 0.95 (0.53 to 1.70) P = 0.86
Occupation
Employed 78.7 (216) 1 NS
Unemployed 82.8 (96) 1.28 (0.73 to 2.32) P = 0.38
Other 84.6 (39) 1.50 (0.59 to 3.84) P = 0.40
Marital status
Ever married 76.3 (118) 1 NS
Committed to someone 79.4 (175) 1.21 (0.69 to 2.09) P = 0.52
Single 89.7 (78) 2.69 (1.23 to 6.27) P = 0.02
Reported sexual behavior
Number of lifetime sexual partners
Less than 8 81.2 (181) 1 NS
8 or more 80.0 (190) 0.93 (0.55 to 1.50) P = 0.77
Linear trend NA 1.00 (0.98 to 1.01) P = 0.60
Number of sexual partners in the past 12 months
Less than 2 81.2 (181) 1 NS
2 or more 79.8 (188) 0.91 (0.54 to 1.48) P = 0.73
Linear trend NA 0.97 (0.91 to 1.03) P = 0.30
Ever used a condom
Yes 81.6 (315) 1 NS
No 75.0 (56) 0.68 (0.35 to 1.31) P = 0.39
Consistent condom use in the past 12 months, with non-spousal partners
Yes 81.3 (96) 1 NS
No 80.4 (179) 0.95 (0.50 to 1.79) P = 0.87
Attitudes towards HIV and awareness of HIV status
Perceived risk of infection with HIV
No or small risk 81.1 (159) 1 NS
Average or high risk 82.7 (139) 1.11 (0.62 to 2.02) P = 0.72
Aware of HIV status
Yes 81.0 (121) 1 NS
No 80.4 (250) 0.96 (0.55 to 1.70) P = 0.89
Knowledge, attitudes and beliefs towards AMC
AMC protects fully against HIV
Disagree 80.3 (229) 1 NS
Agree 86.2 (58) 1.50 ( 0.68 to 3.40) P = 0.31
Most women prefer circumcised men
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Page 9 of 12knowledge about the effect of AMC on HIV acquisition
is fairly good among men from the general population,
there is still a sizeable proportion who think that cir-
cumcised men are not at risk of getting HIV and do not
need to use condoms for protection against HIV and
other STIs. Lastly, what AMC campaigns report about
issues of sexual pleasure and partners’ preference may
have some implications on AMC uptake. In the present
study, some men, in particular those who are self-
reporting as circumcised, have the beliefs that AMC
increases sexual pleasure and that women might prefer
circumcised men. However, scientific evidence on this
issue has not been established [27,28].
Conclusion
This study demonstrates that AMC roll-out is a promis-
ing intervention against the HIV epidemic in Africa but
that it will require careful design and comprehensive
communication strategies to be successful.
Additional material
Additional File 1: Calculating HIV incidence and multivariate HIV
incidence rate ratio using the BED assay results. This file provides
mathematical formulas, as well as calculation details, which were used
for the computation of the HIV incidence rate and the multivariate HIV
incidence rate ratio, using the BED assay results with corrections for
misclassifications.
Table 3 Factors associated with intention to undergo free medicalised adult male circumcision (AMC) among self-
reported uncircumcised men aged 22 and over (Continued)
Disagree 71.7 (53) 1 NS
Agree 84.6 (208) 2.20 (1.10 to 4.40) P = 0.032
AMC increases sexual pleasure
Disagree 78.9 (71) 1 NS
Agree 86.4 (132) 1.70 (0.80 to 3.60) P = 0.17
Circumcised men need to use condoms for protection against HIV and other STIs
Disagree 72.2 (18) 1 NS
Agree 82.6 (322) 1.80 (0.63 to 5.30) P = 0.27
Circumcised men can become infected with HIV
Disagree 100 (10) 1 NS
Agree 80.4 (337) NC
My partner supports AMC
Disagree 63.4 (82) 1 1
Agree 87.3(158) 4.03 (2.10 to 7.60) P < 0.001 2.59 (1.20 to 5.61) P = 0.02
My family supports AMC
Disagree 68.8 (141) 1 1
Agree 90.6 (170) 4.41 (2.33 to 8.20) P < 0.001 2.92 (1.41 to 6.03) P = 0.005
AMC is safe when it is carried out by a doctor
Disagree 38.5 (13) 1 1
Agree 83.6 (336) 8.18 (2.61 to 25.9) P < 0.001 11.01 (3.10 to 39.04) P < 0.001
Sexually Transmitted Infection
HIV infection
No 81.6 (277) 1 NS
Yes 77.7 (94) 0.78 (0.44 to 1.42) P = 0.41
HSV-2 infection
No 82.8 (239) 1 NS
Yes 76.5 (101) 0.67 (0.39 to 1.10) P = 0.14
1 Obtained using logistic regression
2 Obtained using forward stepwise logistic regression with all the variables indicated in this table
N: Sample size
CI: Confidence interval
P: P-value
NS: Not selected by the forward stepwise logistic regression
NA: Not available
NC: Not calculable
STI: sexually transmitted infection
HSV-2: Herpes Simplex Virus 2
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